HYD-PEP-06

N/A

Report date: 2023/12/06 13:55:05
NME

Base Information

Drug NameHYD-PEP-06
Drug Alias NameHYD-PEP06HYD-PEP-06
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin modulators
TargetsIntegrin
Therapy Area/IndicationsSolid tumoursColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJilin Harbin Medical University Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHeilongjiang Harbin Medical University Pharmaceutical Co LtdZhuhai Tengbai Medicine Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A